MLP SE logo

MLP SE (MLP)

Market Closed
15 Dec, 20:00
6. 85
-0.03
-0.44%
- Market Cap
16 P/E Ratio
0% Div Yield
0 Volume
0 Eps
6.88
Previous Close
Day Range
6.84 6.93
Year Range
5.81 9.09
Want to track MLP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 87 days

Summary

MLP closed today lower at €6.85, a decrease of 0.44% from yesterday's close, completing a monthly decrease of -3.66% or €0.26. Over the past 12 months, MLP stock gained 11.56%.
MLP is not paying dividends to its shareholders.
The last earnings report, released on Nov 13, 2025, missed the consensus estimates by -0.09%. On average, the company has fell short of earnings expectations by -0.06%, based on the last three reports. The next scheduled earnings report is due on Mar 12, 2026.
The stock of the company had never split.
The company's stock is traded on 10 different exchanges and in various currencies, with the primary listing on XWBO (EUR).

MLP Chart

MLP SE (MLP) FAQ

What is the stock price today?

The current price is €6.85.

On which exchange is it traded?

MLP SE is listed on XWBO.

What is its stock symbol?

The ticker symbol is MLP.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 0.28.

When is the next earnings date?

The next earnings report will release on Mar 12, 2026.

Has MLP SE ever had a stock split?

No, there has never been a stock split.

MLP SE Profile

Diversified REITs Industry
Real Estate Sector
Mr. Yuehui Xie CEO
XSTU Exchange
DE0006569908 ISIN
CN Country
1,395 Employees
23 Aug 1970 Last Dividend
- Last Split
- IPO Date

Overview

LifeTech Scientific Corporation is a prominent investment holding entity with a primary focus on the development, manufacture, and trade of interventional medical devices tailored for cardiovascular and peripheral vascular diseases and disorders. The company's operations are stratified into three main segments: Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business. Established in 1999 and headquartered in Shenzhen, the People's Republic of China, LifeTech has expanded its operational footprint to include Mainland China, India, the rest of Asia, Europe, South America, and Africa, catering to a global clientele. Besides its core activities in the medical arena, the company also engages in properties leasing, biomedical research and development, and provision of technical, consulting, and technology services. Additionally, LifeTech has ventured into the manufacturing and trading of materials for hemp, underlining its commitment to diverse business interests.

Products and Services

  • LAmbre Left Atrial Appendage Closure Systems

    A cutting-edge solution designed to prevent stroke in patients with non-valvular atrial fibrillation by effectively sealing off the left atrial appendage.

  • CeraFlex, Cera, Heart, and Konara-MF VSD Occluders

    Innovative devices aimed at the treatment of ventricular septal defects (VSD), aiding in the closure of openings between the heart's ventricles.

  • Ankura Thoracic Aortic Aneurysm and Abdominal Aortic Aneurysm Stent Graft Systems

    Stent graft systems designed for the repair of thoracic and abdominal aortic aneurysms, preventing the risk of aneurysm rupture.

  • Delivery Systems: Fustar Steerable and SteerEase Introducers

    Advanced delivery systems that facilitate the accurate placement of devices during interventional procedures, enhancing safety and efficiency.

  • Aegisy Vena Cava Filters

    Devices implanted to prevent pulmonary embolism by catching blood clots before they can travel to the lungs.

  • Cera Vascular Plug Systems

    Designed for the purpose of embolization, these plug systems are used to block abnormal blood vessels to prevent blood flow.

  • AcuMark Sizing Balloons

    These balloons are used for precise measurements within cardiovascular structures, crucial for the successful implantation of interventional devices.

  • LawMax Dilators

    Utilized in procedures requiring the dilation of narrow or obstructed vascular passages, ensuring smooth device passage.

  • SeQure Snare Systems

    A retrieval system designed for the non-surgical removal of misplaced or dislodged interventional devices within the vasculature.

  • Pacemakers

    Highly reliable devices that provide electrical stimulation to maintain adequate heart rate and rhythm in patients with bradycardia.

Contact Information

Address: LifeTech Scientific Building
Phone: 86 75 5860 26250